UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): June 15, 2004
APOGENT TECHNOLOGIES INC.
(Exact name of registrant as specified in its charter)
| | | | |
Wisconsin | | 1-11091 | | 22-2849508 |
(State or other jurisdiction of incorporation) | | (Commission File Number) | | (I.R.S. Employer Identification No.) |
| | |
30 Penhallow Street Portsmouth, New Hampshire | | 03801 |
(Address of principal executive offices) | | (Zip Code) |
(603) 433-6131
Registrant’s telephone number, including area code
Item 5. Other Items
On June 15, 2004, Apogent Technologies Inc. (“Apogent”) and Fisher Scientific International Inc. issued a joint press release announcing that they have provided conversion rights notices to the holders of Apogent’s Floating Rate Senior Convertible Contingent Debt Securities due 2033 and Apogent’s 2.25 percent Senior Convertible Contingent Debt Securities due 2021. The press release is attached as Exhibit 99.1.
Item 7. Financial Statements and Exhibits.
(c) Exhibits
| | |
Exhibit Number
| | Description
|
99.1 | | Press release dated June 15, 2004, announcing that Apogent and Fisher Scientific have provided conversion rights notices to the holders of Apogent’s Floating Rate Senior Convertible Contingent Debt Securities due 2033 and Apogent’s 2.25 percent Senior Convertible Contingent Debt Securities due 2021. |
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| | | | |
| | APOGENT TECHNOLOGIES INC. |
| | (Registrant) |
| | |
Date: June 16, 2004 | | By: | | /s/ Michael K. Bresson
|
| | | | Michael K. Bresson |
| | | | Executive Vice President – Administration General Counsel and Secretary |
EXHIBIT INDEX
| | |
Exhibit No.
| | Description
|
99.1 | | Press release dated June 15, 2004, announcing that Apogent and Fisher Scientific have provided conversion rights notices to the holders of Apogent’s Floating Rate Senior Convertible Contingent Debt Securities due 2033 and Apogent’s 2.25 percent Senior Convertible Contingent Debt Securities due 2021. |